Research ArticleGinsenoside Rg3 (cas 11019-45-7) suppresses mast cell–mediated allergic inflammation via mitogen-activated protein kinase signaling pathway

Add time:08/25/2019    Source:sciencedirect.com

BackgroundGinsenoside Rg3 (G-Rg3) is the major bioactive ingredient of Panax ginseng and has many pharmacological effects, including antiadipogenic, antiviral, and anticancer effects. However, the effect of G-Rg3 on mast cell–mediated allergic inflammation has not been investigated.

We also recommend Trading Suppliers and Manufacturers of Ginsenoside Rg3 (cas 11019-45-7). Pls Click Website Link as below: cas 11019-45-7 suppliers

Prev:Molecular and cellular pharmacology20(S)-Ginsenoside Rg3 (cas 11019-45-7) sensitizes human non-small cell lung cancer cells to icotinib through inhibition of autophagy
Next:Research ArticleGINSENOSIDE RB2 (cas 11021-13-9) suppresses the glutamate-mediated oxidative stress and neuronal cell death in HT22 cells)